BSE Announcement

360 One Wam will hold a meeting of the Board of Directors of the Company on 22 April 2025.

AAVAS Financiers will hold a meeting of the Board of Directors of the Company on 24 April 2025.

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Carbamazepine Tablets USP, 200 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Tegretol Tablets, 200 mg, of Novartis Pharmaceuticals Corporation. Carbamazepine Tablets USP, 200 mg are indicated for use as an anticonvulsant drug. It is also indicated in the treatment of the pain associated with true trigeminal neuralgia. Refer label for a detailed indication.

Carbamazepine Tablets USP, 200 mg have an estimated market size of US$ 32 million for twelve months ending December 2024 according to IQVIA.

Alembic has a cumulative total of 222 ANDA approvals (196 final approvals and 26 tentative approvals) from USFDA.

Alkem Laboratories announced that its wholly owned subsidiary, Alkem MedTech has completed the acquisition of Bombay Ortho Industries. Accordingly, Bombay Ortho Industries has become a step-down subsidiary of the company.

Angel One announced that the Board of Directors of the Company at its meeting held on 16 April 2025, inter alia, have recommended the final dividend of Rs 26 per equity Share (i.e. 260%) , subject to the approval of the shareholders.

The Board of Astral at its meeting held on 17 April 2025 has approved the acquisition of 100% equity share capital of Al-Aziz Plastics for a cash consideration of up to Rs 33 crore.

Al-Aziz Plastics is engaged in the business of manufacture of electrofusion fittings, compression fittings, saddles, electrical fittings, Irrigation Sprinklers and Filters, solar fittings, and accessories for the distribution of water, gas, electricity and solar power for last more than 25 years.

AWFIS Space Solutions (Awfis) announced a strategic partnership with ECOS (India) Mobility & Hospitality to offer premium chauffeur-driven and employee transportation services to its clients nationwide. This collaboration marks a significant expansion of Awfis' service portfolio, addressing the growing need for reliable, secure, and cost-effective corporate mobility solutions.

Commenting on the partnership, Amit Ramani, Chairman & Managing Director, Awfis Space Solutions, said, At Awfis, we have always believed that workspace solutions extend beyond physical offices. With this partnership, we are enhancing the overall business experience by providing seamless transport solutions that complement our workspace offerings. This partnership is a validation of Awfis' commitment to innovation and client satisfaction, and we look forward to working with ECOS Mobility to transform the corporate mobility landscape in India.

Bajaj Finance has allotted 50,000 NCDs of face value of Rs. 1,00,000 each aggregating to Rs.500 crore on private placement basis on 17 April 2025.

Bhansali Engineering Polymers will hold a meeting of the Board of Directors of the Company on 26 April 2025.

Choice International will hold a meeting of the Board of Directors of the Company on 22 April 2025.